MDM2 and sarcoma: In a previous study, loss of one but not both alleles of Mdm2 led to an increase in the number of primary tumors, sarcoma development, and a slight (6 day) statistically significant delay in tumorigenesis in p53-null mice [14], suggesting a p53-independent consequence of Mdm2 haploinsufficiency.